Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289746605> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4289746605 endingPage "65" @default.
- W4289746605 startingPage "60" @default.
- W4289746605 abstract "Background: Drug-drug interactions can often lead to preventable adverse drug events and hospitalization. However, the clinical outcome of a potential drug-drug interaction that may range from minor alterations to major toxicity or loss of effect is often unknown. Drugs with narrow therapeutic index are more susceptible to the outcomes of interactions. Anticoagulants are one of the drug groups prone to drug-drug interactions and have important side effects. in this retrospective study, the frequency of drug-drug interactions involving warfarin, heparin and enoxaparin was investigated. Methods: Overall, 300 patients (including 55% males with an average age of 50.75 years) participated in this study, and for each anticoagulant, 100 patient orders were randomly selected from the hospital system. Drug-drug interactions were evaluated using the Micromedex drug interaction checker. Results: A total of 1691 drug-drug interactions (306 major, 253 moderate, and 89 minor interactions) were recorded of which only 648 (average 2.16) involved warfarin, heparin, or enoxaparin. Most interactions were recorded in patients admitted to the cardiovascular surgery (n=312) and cardiology (n=119) wards. There was a significant relationship between the number of drugs and the frequency of interaction. warfarin had the highest number of interactions (n=388). Conclusion: The frequency of drug interactions is high in patients on anticoagulant therapy. The efficacy and safety of these drugs can be affected by drug interactions. Accordingly, these interactions should always be considered, especially in patients with multiple drug use. Efficient monitoring strategies should be employed to optimize treatment while reducing adverse effects." @default.
- W4289746605 created "2022-08-04" @default.
- W4289746605 creator A5023073340 @default.
- W4289746605 creator A5025403583 @default.
- W4289746605 creator A5052905730 @default.
- W4289746605 creator A5072593061 @default.
- W4289746605 creator A5075173628 @default.
- W4289746605 creator A5079987612 @default.
- W4289746605 date "2021-12-30" @default.
- W4289746605 modified "2023-09-30" @default.
- W4289746605 title "Potential Drug-Drug Interactions in Patients Using Warfarin, Heparin, and Enoxaparin" @default.
- W4289746605 doi "https://doi.org/10.34172/ajpr.2021.12" @default.
- W4289746605 hasPublicationYear "2021" @default.
- W4289746605 type Work @default.
- W4289746605 citedByCount "0" @default.
- W4289746605 crossrefType "journal-article" @default.
- W4289746605 hasAuthorship W4289746605A5023073340 @default.
- W4289746605 hasAuthorship W4289746605A5025403583 @default.
- W4289746605 hasAuthorship W4289746605A5052905730 @default.
- W4289746605 hasAuthorship W4289746605A5072593061 @default.
- W4289746605 hasAuthorship W4289746605A5075173628 @default.
- W4289746605 hasAuthorship W4289746605A5079987612 @default.
- W4289746605 hasBestOaLocation W42897466051 @default.
- W4289746605 hasConcept C126322002 @default.
- W4289746605 hasConcept C177713679 @default.
- W4289746605 hasConcept C197934379 @default.
- W4289746605 hasConcept C19831878 @default.
- W4289746605 hasConcept C2776301958 @default.
- W4289746605 hasConcept C2777557582 @default.
- W4289746605 hasConcept C2778205648 @default.
- W4289746605 hasConcept C2779161974 @default.
- W4289746605 hasConcept C2780035454 @default.
- W4289746605 hasConcept C2910466267 @default.
- W4289746605 hasConcept C2911117829 @default.
- W4289746605 hasConcept C71924100 @default.
- W4289746605 hasConcept C97320921 @default.
- W4289746605 hasConcept C98274493 @default.
- W4289746605 hasConceptScore W4289746605C126322002 @default.
- W4289746605 hasConceptScore W4289746605C177713679 @default.
- W4289746605 hasConceptScore W4289746605C197934379 @default.
- W4289746605 hasConceptScore W4289746605C19831878 @default.
- W4289746605 hasConceptScore W4289746605C2776301958 @default.
- W4289746605 hasConceptScore W4289746605C2777557582 @default.
- W4289746605 hasConceptScore W4289746605C2778205648 @default.
- W4289746605 hasConceptScore W4289746605C2779161974 @default.
- W4289746605 hasConceptScore W4289746605C2780035454 @default.
- W4289746605 hasConceptScore W4289746605C2910466267 @default.
- W4289746605 hasConceptScore W4289746605C2911117829 @default.
- W4289746605 hasConceptScore W4289746605C71924100 @default.
- W4289746605 hasConceptScore W4289746605C97320921 @default.
- W4289746605 hasConceptScore W4289746605C98274493 @default.
- W4289746605 hasIssue "2" @default.
- W4289746605 hasLocation W42897466051 @default.
- W4289746605 hasOpenAccess W4289746605 @default.
- W4289746605 hasPrimaryLocation W42897466051 @default.
- W4289746605 hasRelatedWork W2051853915 @default.
- W4289746605 hasRelatedWork W2297372844 @default.
- W4289746605 hasRelatedWork W2426288497 @default.
- W4289746605 hasRelatedWork W2567767604 @default.
- W4289746605 hasRelatedWork W2617874505 @default.
- W4289746605 hasRelatedWork W3005771968 @default.
- W4289746605 hasRelatedWork W4231756108 @default.
- W4289746605 hasRelatedWork W4289746605 @default.
- W4289746605 hasRelatedWork W2186546809 @default.
- W4289746605 hasRelatedWork W2465996581 @default.
- W4289746605 hasVolume "2" @default.
- W4289746605 isParatext "false" @default.
- W4289746605 isRetracted "false" @default.
- W4289746605 workType "article" @default.